Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Solid Biosciences Inc (SLDB)

Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Insider Sale: President and CEO of $SLDB (SLDB) Sells 11,114 Shares Quiver Quantitative, Inc. - Thu Dec 5, 2:40AM CST

Alexander Cumbo, the President and CEO of $SLDB ($SLDB), sold 11,114 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 22.4%...

SLDB : 4.16 (+3.74%)
Insider Sale: Chief Technology Officer of $SLDB (SLDB) Sells 2,777 Shares Quiver Quantitative, Inc. - Thu Dec 5, 1:52AM CST

Paul Herzich, the Chief Technology Officer of $SLDB ($SLDB), sold 2,777 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.6%...

SLDB : 4.16 (+3.74%)
Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies GlobeNewswire - Wed Dec 4, 7:00AM CST

SLDB : 4.16 (+3.74%)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Dec 3, 7:00AM CST

SLDB : 4.16 (+3.74%)
Solid Biosciences to Participate at Upcoming Investor Conferences GlobeNewswire - Tue Nov 26, 7:00AM CST

SLDB : 4.16 (+3.74%)
Solid Biosciences to Present at the Jefferies London Healthcare Conference GlobeNewswire - Thu Nov 14, 7:00AM CST

SLDB : 4.16 (+3.74%)
Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates GlobeNewswire - Wed Nov 6, 3:05PM CST

SLDB : 4.16 (+3.74%)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Mon Nov 4, 7:00AM CST

SLDB : 4.16 (+3.74%)
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium GlobeNewswire - Thu Oct 31, 7:00AM CDT

SLDB : 4.16 (+3.74%)
Author
Are Gene Therapy Stocks The Market's Next Big Winners? MarketBeat - Mon Sep 25, 2023

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

SRPT : 118.97 (-0.42%)
BMRN : 65.66 (+1.02%)
BIIB : 146.47 (-0.62%)
CRSP : 40.72 (+0.83%)
EDIT : 1.3100 (-2.24%)
NTLA : 12.18 (+0.83%)
NVS : 97.11 (+0.35%)
ORTX : 16.70 (+0.30%)
REGN : 701.85 (-0.90%)
SLDB : 4.16 (+3.74%)
BLUE : 8.50 (-7.91%)

Barchart Exclusives

Is It Time to Sell This Second-Fiddle AI Stock Before 2025? Barchart - 3 minutes ago
Bank of America has cut its rating on AMD while lowering its price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot